Home > Income Statement > MANKIND PHARMA

MANKIND PHARMA
Appropriations

    Back to Income Statement
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
AD     Remove this Ad

MANKIND PHARMA Last 5 Year Appropriations History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Appropriations ₹9,925 Cr₹801,705 Cr₹6,737 Cr₹533 Cr₹44,380 Cr

What is the latest Appropriations of MANKIND PHARMA ?

The latest Appropriations ratio of MANKIND PHARMA is ₹9,925 Cr based on Mar2025 Consolidated results.
Year Appropriations
Mar2025₹9,925 Cr
Mar2024₹801,705 Cr
Mar2023₹6,737 Cr
Mar2022₹533 Cr
Mar2021₹44,380 Cr

How is Appropriations of MANKIND PHARMA Trending?

Years Appropriations % Change
Mar2025 ₹9,925 Cr
-98.76
Mar2024 ₹801,705 Cr
11,800.05
Mar2023 ₹6,737 Cr
1,163.76
Mar2022 ₹533 Cr
-98.80
Mar2021 ₹44,380 Cr -

Compare Appropriations of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹87,715.9 Cr 1.1% -1.3% -16.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹382,694.0 Cr -2.3% -7.3% -12.8% Stock Analytics
DIVIS LABORATORIES ₹160,721.0 Cr 0.8% -5.8% 4.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹134,016.0 Cr 0.8% 3.7% 20.8% Stock Analytics
CIPLA ₹106,946.0 Cr 0.7% -11.2% -6.5% Stock Analytics
DR REDDYS LABORATORIES ₹101,691.0 Cr -1.4% -3.8% -1.3% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

1.1%

-1.3%

-16.1%

SENSEX

-0.1%

-2.9%

7.5%


You may also like the below Video Courses